CORAL SPRINGS, Florida, August 14, 2014 /PRNewswire/ --
Security and Surveillance needs become top priority in Cannabis / Legal Marijuana industry as sector continues expansion and growth for the following emerging companies: DirectView Holdings, Inc. (OTC: DIRV), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH), Singlepoint, Inc. (OTC: SING) and Cannabis Science, Inc. (CBIS).
DirectView Holdings, Inc. (OTC Pink: DIRV), a company focused on ownership and management of leading video and security technology companies, today announced that it has been selected by a Colorado-based cannabis facility to complete a comprehensive security and surveillance installation. The selection is a direct result of its recent strategic partnership agreement with Cannamor, LLC ("Cannamor"), a privately held Colorado based consulting company focused on legal cannabis growing and dispensing projects.
DirectView has been selected to install a comprehensive package of security and surveillance equipment at the facility including the company installing the DirectView IP megapixel security cameras, NVR's and a comprehensive intrusion alarm system Work at the facility has been initiated and the Company expects to complete the installation in the current quarter.
To read the full DIRV press release, please click here:http://www.financialnewsmedia.com/profiles/dirv.html
Roger Ralston, CEO and Chairman of DirectView, stated: "We are excited to continue to expand our security presence in the cannabis industry. This installation marks the first step in what we believe will be a highly productive and long standing relationship with Cannamor. We look forward to completing the work at this facility in the current quarter and further our growth in this important business vertical."
In Security Solution Providers News, the Composite Value of the Security & Protection Services Index was up slightly over 1.89% led by Price Performance Leaders The ADT Corp (NYSE: ADT), Kratos Defense & Security Solutions (NASDAQ: KTOS) and The Brinks Company (NYSE: BCO) all trading up on Wednesday (08/13/2014).
Nuvilex, Inc. (OTCQB: NVLX) a clinical-stage, international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, recently announced that it is providing shareholders with an update on the status of Nuvilex's preclinical studies to be conducted by Translational Drug Development (TD2) in Scottsdale, Arizona. The CEO and President of Nuvilex, Kenneth L. Waggoner, said, "In an effort to keep our shareholders informed on the very important preclinical studies to determine if Nuvilex's unique treatment of cancer can slow the accumulation of fluid in the abdomen, known as "malignant ascites," that is characteristic of the growth of many abdominal tumors, including pancreatic cancer, we wanted to announce that the encapsulated cells that will be used in the preclinical studies have arrived in the U.S. These are the encapsulated calls capable of converting the anticancer prodrug ifosfamide into its cancer-killing form using the Cell-in-a-Box[(R)] cellulose-based live cell encapsulation technology. With the arrival of the encapsulated cells, the preclinical studies are now slated to begin at TD2 the week of August 18, 2014."
GW Pharmaceuticals plc (NASDAQ: GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, recently announced financial results for the third quarter and nine months ended 30 June 2014. Financial highlights include: Revenue for the three months ended 30 June 2014 of [Pounds]7.6 million ($13.0 million) compared to [Pounds]7.3 million for the three months ended 30 June 2013, loss for the three months ended 30 June 2014 of [Pounds]6.9 million ($11.9 million) compared to a loss of [Pounds]2.0 million for the three months ended 30 June 2013. The increased loss primarily reflects the planned increase in GW funded R&D in order to fund the development of Epidiolex and other pipeline candidates. Cash and cash equivalents at 30 June 2014 of [Pounds]168.3 million ($287.8 million) compared to [Pounds]38.1 million as at 30 September 2013. To read the full report, please click here: http://finance.yahoo.com/news/gw-pharmaceuticals-plc-reports-2014-060000645.html
Singlepoint, Inc. (OTC Pink: SING) recently announced that GreenStar Payment Solutions, Inc., the Company's joint venture specializing in cashless solutions for cannabis/medical marijuana clinics and dispensaries, has secured Agreements with clinics and dispensaries in Arizona, Washington and Oregon. These accounts mark GreenStar's official stake in the medical marijuana marketplace (#mmj) marketplace toward becoming a leading competitor, with a primary focus of securing accounts and lateral initiatives to acquire others in this space. "We are elated with the success of GreenStar to date," states SinglePoint CEO and GreenStar co-founder, Greg Lambrecht. "The venture was formed recently, in late May 2014, and we've expedited the formation of our corporate infrastructure in just over a month, all the while using our teams to harvest leads toward actionable contracts. We are excited that in our first 2 weeks of active sales, we have closed 7 accounts with 3-5 more expected this week."
Cannabis Science, Inc. (CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, recently announced it has signed a binding letter of intent with its existing Michigan partners, increasing Cannabis Science's equity position from 20% to 50.1% in its joint venture in the Michigan medical cannabis and hemp markets, Michigan Green Technologies LLC (MGT). MGT is the leading resource for legislative initiatives and management consulting in Michigan with regard to cannabinoid-based drug development, nutraceuticals, food supplements, cosmeceuticals and food products. As the State of Michigan progresses and matures its legislative environment, the prospects for delivering cannabis-based patient care are rapidly growing. Michigan's open-minded approach to legislation is likely to make it a leading US state in which cannabis-based care is fully integrated into the general healthcare system, thus providing quality and safety to patients. MGT operations are expected to include the opening of a hemp-based product retail facility in early 2015, followed by medical cannabis operations.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand seven hundred dollars for news coverage of the current press release issued by DirectView Holdings, Inc. by the company.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
SOURCE FN Media Group, LLC